Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-03-20
2007-03-20
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S259200, C514S222200, C544S003000, C544S278000, C540S552000
Reexamination Certificate
active
11138726
ABSTRACT:
The invention encompasses a series cyclic bicyclic heterocyclic compounds of Formula I which are inhibitors of HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV
REFERENCES:
patent: 2004/0006065 (2004-01-01), Glunz
patent: WO 2003/035076 (2003-05-01), None
patent: WO 2003/035077 (2003-05-01), None
patent: WO 2004/058756 (2004-07-01), None
patent: WO 2004/058757 (2004-07-01), None
patent: WO 2005/061490 (2005-07-01), None
patent: WO 2005/061501 (2005-07-01), None
patent: WO 2006/060731 (2006-06-01), None
patent: WO 2006/103399 (2006-10-01), None
U.S. Appl. No. 10/755,642, filed Jan. 12, 2004, Michael A. Walker, et al.
Banville Jacques
Bouthillier Gilles
Naidu B. Narasimhulu
Remillard Roger
Walker Michael A.
Berch Mark L.
Bristol--Myers Squibb Company
Epperson James
Moore Susanna
LandOfFree
Bicyclic heterocycles as HIV integrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic heterocycles as HIV integrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic heterocycles as HIV integrase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3772740